R.H. Bluestein & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $353K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $784K | Sell |
|
|||||
|
2021
Q4 | $798K | Sell |
|
|||||
|
2021
Q3 | $768K | Buy |
|
|||||
|
2021
Q2 | $601K | Sell |
|
|||||
|
2021
Q1 | $542K | Hold |
|
|||||
|
2020
Q4 | $559K | Sell |
|
|||||
|
2020
Q3 | $644K | Hold |
|
|||||
|
2020
Q2 | $698K | Buy |
|
|||||
|
2020
Q1 | $644K | Buy |
|
|||||
|
2019
Q4 | $705K | Hold |
|
|||||
|
2019
Q3 | $640K | Hold |
|
|||||
|
2019
Q2 | $600K | Hold |
|
|||||
|
2019
Q1 | $627K | Hold |
|
|||||
|
2018
Q4 | $573K | Hold |
|
|||||
|
2018
Q3 | $603K | Hold |
|
|||||
|
2018
Q2 | $605K | Hold |
|
|||||
|
2018
Q1 | $586K | Hold |
|
|||||
|
2017
Q4 | $532K | Sell |
|
|||||
|
2017
Q3 | $1.01M | Hold |
|
|||||
|
2017
Q2 | $1.08M | Sell |
|
|||||
|
2017
Q1 | $1.06M | Hold |
|
|||||
|
2016
Q4 | $969K | Hold |
|
|||||
|
2016
Q3 | $1.08M | Hold |
|
|||||
|
2016
Q2 | $1.09M | Hold |
|
|||||
|
2016
Q1 | $1.02M | Buy |
|
|||||
|
2015
Q4 | $1.01M | Hold |
|
|||||
|
2015
Q3 | $961K | Buy |
|
|||||
|
2015
Q2 | $833K | Buy |
|
|||||
|
2015
Q1 | $692K | Hold |
|
|||||
|
2014
Q4 | $641K | Sell |
|
|||||
|
2014
Q3 | $898K | Sell |
|
|||||
|
2014
Q2 | $1.31M | Sell |
|
|||||
|
2014
Q1 | $1.55M | Buy |
|
|||||
|
2013
Q4 | $1.23M | Sell |
|
|||||
|
2013
Q3 | $1.29M | Sell |
|
|||||
|
2013
Q2 | $1.38M | Buy |
|